SRU Guidelines for Gallbladder Polyps
The 2022 Society of Radiologists in Ultrasound (SRU) guidelines stratify gallbladder polyps into three risk categories based on morphology and size, with management ranging from no follow-up for very small pedunculated polyps to surgical consultation for polyps ≥15 mm. 1
Risk Stratification Framework
The SRU approach uses polyp morphology as the primary determinant of baseline risk, then applies size-based thresholds within each category:
Extremely Low Risk: Pedunculated "Ball-on-the-Wall" or Thin Stalk
- ≤9 mm: No follow-up required
- 10-14 mm: Follow-up ultrasound at 6,12, and 24 months
- ≥15 mm: Surgical consultation 1
Low Risk: Pedunculated with Thick/Wide Stalk or Sessile
- ≤6 mm: No follow-up required
- 7-9 mm: Follow-up ultrasound at 12 months
- 10-14 mm: Follow-up ultrasound at 6,12,24, and 36 months OR surgical consultation (decision based on patient factors)
- ≥15 mm: Surgical consultation 1
Indeterminate Risk: Focal Wall Thickening ≥4 mm Adjacent to Polyp
- ≤6 mm: Follow-up ultrasound at 6,12,24, and 36 months OR surgical consultation
- ≥7 mm: Surgical consultation 1
Key Principles and Evidence Base
The SRU guidelines are notably less aggressive than earlier approaches and other international guidelines, reflecting the extremely low malignancy risk in small polyps. The evidence supporting this conservative approach is robust: no gallbladder cancers were documented in polyps ≤5 mm across multiple systematic reviews, and in a survey of SRU fellows representing approximately 3 million gallbladder ultrasounds, zero cases of malignant polyps <10 mm were identified at initial detection or follow-up 2.
The 15-mm threshold for mandatory surgical consultation is based on data showing this size as an independent risk factor for neoplastic lesions, with neoplastic polyps averaging 18.1-18.5 mm versus 7.5-12.6 mm for benign polyps 2.
Practical Application and Reliability
Radiologists demonstrate substantial interreader agreement when applying these guidelines (kappa = 0.710 for risk categorization, 0.795 for surgical consultation recommendations), supporting their reproducibility in clinical practice 3. However, variability exists: across 10 radiologists reviewing the same polyps, the percentage classified as extremely low risk ranged from 32-72%, and surgical consultation recommendations ranged from 4-22% 3.
Comparison with Other Guidelines
The SRU guidelines are significantly more specific but less sensitive than the 2021 Joint European Societies (JES) guidelines. In a comparative study of polyps ≥7 mm, SRU guidelines achieved 90% specificity versus 41% for JES, while JES achieved 90% sensitivity versus 62% for SRU 4. This translates to fewer surgical referrals under SRU criteria, which may be more appropriate for low-incidence populations in North America and Europe 4.
The European guidelines recommend cholecystectomy for all polyps ≥10 mm and for 6-9 mm polyps with risk factors (age >60, primary sclerosing cholangitis, Asian ethnicity, sessile morphology), whereas SRU reserves mandatory surgical consultation for ≥15 mm polyps and allows observation for 10-14 mm polyps depending on morphology 1.
Critical Caveats
Polyp size fluctuation is common and does not necessarily indicate malignancy. Nearly half of polyps show dynamic changes, increasing or decreasing by 2-3 mm over time as part of their natural history 2. Growth of small polyps (<10 mm) during surveillance is expected and should not automatically trigger surgical referral unless other high-risk features are present.
Echogenicity is nonspecific: while all neoplastic polyps in one series were more echogenic than the adjacent gallbladder wall, this feature was also present in 56% of benign polyps 5. Do not use echogenicity alone to determine management.
The guidelines assume exclusion of features highly suspicious for invasive or malignant tumors at initial evaluation. If there is concern for gallbladder carcinoma based on imaging characteristics (irregular wall thickening, loss of wall-lumen interface, invasion into liver), immediate surgical consultation is warranted regardless of polyp size.